Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
4
×
boston blog main
clinical trials
fda
4
×
life sciences
national blog main
boston top stories
deals
investing
ipo
renaissance capital
san diego blog main
san diego top stories
san francisco blog main
480 biomedical
akouos
antibiotics
arsenal medical
arvinas
astellas pharmaceuticals
astrazeneca
biotech ipos
bob langer
boulder/denver
boulder/denver blog main
boulder/denver top stories
california institute for biomedical research
carbapenem-resistant enterobacteriaceae
celgene
chronic rhinosinusitis
covid-19
decibel therapeutics
detroit
detroit blog main
detroit top stories
drug delivery
drugs
dyne therapeutics
entasis therapeutics
What
ipo
4
×
company
developing
therapeutics
drug
medicines
million
raised
treat
way
affects
americans
approved
biotech
biotechs
brings
chose
close
date
debut
device
disorders
dyne
dyne’s
fda
firms
frequency
genetic
hearing
ipos
late
life
loss
lyra
make
markets
medical
meds
millions
muscle
Language
unset
Current search:
ipo
×
boston
×
fda
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way